b'SIU EVENTS4th B2B Uro-Oncology: GU Cancers TriadIn conjunction with SIU 2022SCIENTIFIC PROGRAMME COMMITTEEPeter BlackAlexandraSimon Tanguay Derya Tilki (Canada) Masson-Lecomte(Canada) (Germany)(France)ABOUT THE MEETINGWatch world-renowned experts present the latest advances in the management of thethree most prevalent GU cancers: bladder, kidney, and prostate. Interact with the facultyand participate in dynamic discussions on the evolving management of GU cancers.LEARNING OBJECTIVESThe overarching goal of the programme is to understand and increase participants abilitiesto review and evaluate recent research findings in the field of GU oncology and apply these Watch this sessionto clinical care, with the goal of improving clinical outcomes and patient quality of life. on-demand onAt the end of this programme, participants will be able to: SIU@U untilEvaluate the benefits and risks of various treatment options across the treatment December 31, 2022 continuum in UC, RCC, and PCa.Analyze novel agents and treatment approaches for the evolving management of As of January 2, 2023, watch GU cancers based on emerging clinical data. this session on SIU Academy Discuss strategies to identify and manage adverse events related to systemic treatment,or the SIU Academy mobile including immunotherapy. app. Claim your CME credits Evaluate the role of imaging or genetic markers in guiding treatment decision-making. until November 13, 2023.Discuss the importance of personalized medicine, based on costs and patient preference,while minimizing toxicity and maximizing efficacy. This educational programme is supported by:CORPORATE SPONSORCONTRIBUTING SPONSORS10 SIUuMAG|NOVEMBER 2022, VOLUME 3, NO. 3'